NCT03023059View on ClinicalTrials.gov

Dose Ranging Study of Carbidopa-levodopa

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 2, 2017

Primary Completion Date

March 18, 2020

Study Completion Date

May 4, 2020

Conditions
Age-related Macular Degeneration
Interventions
DRUG

Carbidopa-Levodopa, 25 Mg-100 Mg Oral Tablet

See Arm description

Trial Locations (1)

85712

Robert W Snyder, MD, PhD, PC, Tucson

All Listed Sponsors
lead

Snyder, Robert W., M.D., Ph.D., P.C.

INDIV

NCT03023059 - Dose Ranging Study of Carbidopa-levodopa | Biotech Hunter | Biotech Hunter